Slapak Christopher 4
4 · Vor Biopharma Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Slapak Christopher
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-01+116,000→ 116,000 totalExercise: $8.63Exp: 2032-01-31→ Common Stock (116,000 underlying)
Footnotes (1)
- [F1]This option vests over four years in equal monthly installments beginning on February 1, 2022.